CrossRef The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management Carlo Acierno, Riccardo Nevola, Fannia Barletta, Katarzyna Zieliska, Luca Rinaldi, Ferdinando Carlo Sasso, Caterina Conte, Luigi Elio Adinolfi, Alfredo Caturano Exploration of Medicine .2025;[Epub] CrossRef The effects of salvia hispanica (chia seeds) on insulin sensitivity, hematological inflammatory indices and liver function in obese patients with non-alcoholic fatty liver disease (NAFLD) Sara Arefhosseini, Maryam Parimi, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani Nutrition & Metabolism .2025;[Epub] CrossRef Prevalence and Risk Factors of Metabolic DysfunctionAssociated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh JMIR Diabetes .2025

The appetite and digestion-suppressing side effects have made Ozempic appealing to patients who want to curb cravings and lose weight
If a platform approves you for semaglutide without any physician review or consultation (even asynchronous), that is a serious concern
The best places to give the injection are the upper arms, stomach, or upper legs
Both are investigational: Neither eloralintide nor retatrutide is FDA-approved
Work schedule and lifestyle considerations are equally important